$CTCX
Carmell Corp

2023 Q3 Form 10-Q Financial Statement

#000119312523212538 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $3.729M $0.00
YoY Change
Cost Of Revenue $1.544M $0.00
YoY Change
Gross Profit $2.185M $0.00
YoY Change
Gross Profit Margin 58.6%
Selling, General & Admin $4.495M $1.160M
YoY Change 3528.56% 305.76%
% of Gross Profit 205.71%
Research & Development $1.672M $823.7K
YoY Change 192.84%
% of Gross Profit 76.52%
Depreciation & Amortization $429.5K $26.27K
YoY Change 1718.35%
% of Gross Profit 19.66%
Operating Expenses $7.322M $1.160M
YoY Change 5811.33% 305.76%
Operating Profit -$5.137M -$1.161M
YoY Change 4047.32% 306.29%
Interest Expense $4.314M $1.870M
YoY Change 517.74% 810.86%
% of Operating Profit
Other Income/Expense, Net -$6.327M -$3.822M
YoY Change 21.32%
Pretax Income -$11.46M $706.1K
YoY Change -2095.91% -976.32%
Income Tax $0.00 $388.6K
% Of Pretax Income 55.04%
Net Earnings -$11.46M $317.5K
YoY Change -1463.52% -191.51%
Net Earnings / Revenue -307.46%
Basic Earnings Per Share -$0.62 -$5.00
Diluted Earnings Per Share -$0.62 $0.02
COMMON SHARES
Basic Shares Outstanding 19.24M 1.125M
Diluted Shares Outstanding 18.63M 1.125M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.969M $0.00
YoY Change 2014.61% -100.0%
Cash & Equivalents $7.968M $10.24K
Short-Term Investments
Other Short-Term Assets $0.00 $100.0K
YoY Change -100.0% 55.74%
Inventory $9.808M
Prepaid Expenses $1.312M $54.19K
Receivables $14.40M
Other Receivables $0.00
Total Short-Term Assets $38.87M $64.43K
YoY Change 7246.72% -89.54%
LONG-TERM ASSETS
Property, Plant & Equipment $289.8K
YoY Change
Goodwill $19.31M
YoY Change
Intangibles
YoY Change
Long-Term Investments $160.2M
YoY Change 3.58%
Other Assets
YoY Change
Total Long-Term Assets $43.35M $160.2M
YoY Change -72.09% 3.6%
TOTAL ASSETS
Total Short-Term Assets $38.87M $64.43K
Total Long-Term Assets $43.35M $160.2M
Total Assets $82.22M $160.3M
YoY Change -47.25% 3.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.79M
YoY Change
Accrued Expenses $3.856M $2.815M
YoY Change 373.28% 298.02%
Deferred Revenue
YoY Change
Short-Term Debt $5.610M $0.00
YoY Change
Long-Term Debt Due $1.721M
YoY Change
Total Short-Term Liabilities $37.71M $4.110M
YoY Change 4439.03% 287.75%
LONG-TERM LIABILITIES
Long-Term Debt $1.498M $0.00
YoY Change
Other Long-Term Liabilities $14.26M $0.00
YoY Change 163.84% -100.0%
Total Long-Term Liabilities $15.76M $0.00
YoY Change 191.55% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $37.71M $4.110M
Total Long-Term Liabilities $15.76M $0.00
Total Liabilities $61.31M $4.110M
YoY Change 883.07% -36.43%
SHAREHOLDERS EQUITY
Retained Earnings -$61.66M -$2.403M
YoY Change 1047.76% -57.43%
Common Stock $2.308K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $20.92M -$2.402M
YoY Change
Total Liabilities & Shareholders Equity $82.22M $160.3M
YoY Change -47.25% 3.23%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$11.46M $317.5K
YoY Change -1463.52% -191.51%
Depreciation, Depletion And Amortization $429.5K $26.27K
YoY Change 1718.35%
Cash From Operating Activities -$5.204M -$10.00K
YoY Change 4871.62% -76.87%
INVESTING ACTIVITIES
Capital Expenditures $30.47K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $663.0K
YoY Change
Cash From Investing Activities $632.5K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.41M 0.000
YoY Change -17830.89%
NET CHANGE
Cash From Operating Activities -5.204M -10.00K
Cash From Investing Activities 632.5K
Cash From Financing Activities 12.41M 0.000
Net Change In Cash 7.840M -10.00K
YoY Change -4588.67% -76.87%
FREE CASH FLOW
Cash From Operating Activities -$5.204M -$10.00K
Capital Expenditures $30.47K
Free Cash Flow -$5.234M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001842939
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Carmell Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity File Number
EntityFileNumber
001-40228
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1645738
dei Entity Address Address Line1
EntityAddressAddressLine1
2403 Sidney Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
dei Entity Address City Or Town
EntityAddressCityOrTown
Pittsburgh
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
15203
dei City Area Code
CityAreaCode
919
dei Local Phone Number
LocalPhoneNumber
313-9633
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
CTCX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19236305
CY2023Q2 us-gaap Cash
Cash
10243
CY2022Q4 us-gaap Cash
Cash
187664
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
54188
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
97538
CY2023Q2 us-gaap Assets Current
AssetsCurrent
64431
CY2022Q4 us-gaap Assets Current
AssetsCurrent
285202
CY2023Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
160236494
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
156693598
CY2023Q2 us-gaap Assets
Assets
160300925
CY2022Q4 us-gaap Assets
Assets
156978800
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2815180
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1258337
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1123151
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
391198
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4110061
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1681514
CY2023Q2 ctcx Deferred Underwriting Fees Payable Noncurrent
DeferredUnderwritingFeesPayableNoncurrent
0
CY2022Q4 ctcx Deferred Underwriting Fees Payable Noncurrent
DeferredUnderwritingFeesPayableNoncurrent
5405436
CY2023Q2 us-gaap Liabilities
Liabilities
4110061
CY2022Q4 us-gaap Liabilities
Liabilities
7086950
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2402891
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6018111
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-2402459
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6017679
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
160300925
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
156978800
CY2023Q2 ctcx Formation General And Administrative Expenses
FormationGeneralAndAdministrativeExpenses
1161478
CY2022Q2 ctcx Formation General And Administrative Expenses
FormationGeneralAndAdministrativeExpenses
285876
ctcx Formation General And Administrative Expenses
FormationGeneralAndAdministrativeExpenses
1917944
ctcx Formation General And Administrative Expenses
FormationGeneralAndAdministrativeExpenses
821018
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1161478
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-285876
us-gaap Operating Income Loss
OperatingIncomeLoss
-1917944
us-gaap Operating Income Loss
OperatingIncomeLoss
-821018
CY2023Q2 ctcx Interest And Dividend Income Non Operating
InterestAndDividendIncomeNonOperating
1867614
CY2022Q2 ctcx Interest And Dividend Income Non Operating
InterestAndDividendIncomeNonOperating
205296
ctcx Interest And Dividend Income Non Operating
InterestAndDividendIncomeNonOperating
3543475
ctcx Interest And Dividend Income Non Operating
InterestAndDividendIncomeNonOperating
212908
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
706136
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-80580
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1625531
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-608110
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
388625
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
266406
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
731953
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
266406
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
317511
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-346986
us-gaap Net Income Loss
NetIncomeLoss
893578
us-gaap Net Income Loss
NetIncomeLoss
-874516
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6017679
CY2023Q1 ctcx Increase In Stockholders Equity Note From Deferred Underwriting Fees Waiver
IncreaseInStockholdersEquityNoteFromDeferredUnderwritingFeesWaiver
5405436
CY2023Q1 ctcx Change In Value Of Temporary Equity Due To Dividend And Interest Earned
ChangeInValueOfTemporaryEquityDueToDividendAndInterestEarned
-1271465
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
576067
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1307641
CY2023Q2 ctcx Change In Value Of Temporary Equity Due To Dividend And Interest Earned
ChangeInValueOfTemporaryEquityDueToDividendAndInterestEarned
-1412329
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
317511
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-2402459
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4762268
CY2022Q1 ctcx Change In Value Of Temporary Equity Due To Dividend And Interest Earned
ChangeInValueOfTemporaryEquityDueToDividendAndInterestEarned
-7612
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-527530
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-5297410
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-346986
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-5644396
us-gaap Profit Loss
ProfitLoss
893578
us-gaap Profit Loss
ProfitLoss
-874516
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
3542896
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
212908
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-43350
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-134769
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1556843
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
492053
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
139751
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-714
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
731953
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
266406
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-177421
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-194910
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
27785
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-177421
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-222695
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
187664
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
774192
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10243
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
551497
ctcx Deferred Underwriting Fees Waiver
DeferredUnderwritingFeesWaiver
5405436
ctcx Deferred Underwriting Fees Waiver
DeferredUnderwritingFeesWaiver
0
CY2023Q2 ctcx Accretion Of Interest Earned In The Trust Account Accrued To Temporary Equity Shareholders
AccretionOfInterestEarnedInTheTrustAccountAccruedToTemporaryEquityShareholders
2683794
CY2022Q2 ctcx Accretion Of Interest Earned In The Trust Account Accrued To Temporary Equity Shareholders
AccretionOfInterestEarnedInTheTrustAccountAccruedToTemporaryEquityShareholders
7612
ctcx Restricted Investments Term
RestrictedInvestmentsTerm
P185D
ctcx Lock In Period For Redemption Of Public Shares After Closing Of Ipo
LockInPeriodForRedemptionOfPublicSharesAfterClosingOfIpo
P24M
CY2023Q2 ctcx Percentage Of Public Shares To Be Redeemed In Case Business Combination Is Not Consummated
PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated
1
CY2021Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.28
CY2023Q2 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
5000001
CY2023Q2 ctcx Percentage Of Public Shares To Be Redeemed In Case Business Combination Is Not Consummated
PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated
1
CY2023Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10
CY2023Q2 us-gaap Cash
Cash
10243
ctcx Maximum Net Interests To Pay Dissolution Expenses
MaximumNetInterestsToPayDissolutionExpenses
100000
CY2023Q2 us-gaap Cash
Cash
10243
CY2023Q2 us-gaap Cash
Cash
10243
CY2023Q2 ctcx Negative Working Capital
NegativeWorkingCapital
4045630
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2402891
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. </div>
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
0
CY2023Q1 ctcx Deferred Underwriting Fees Payable Noncurrent
DeferredUnderwritingFeesPayableNoncurrent
5405436
us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
1:1.2
CY2023Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
160236494
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
156693598
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to a concentration of credit risk consist of a cash account in a financial institution, which at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. </div>
CY2023Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 ctcx Volume Weighted Average Price Of Shares
VolumeWeightedAveragePriceOfShares
9.2
ctcx Proceeds From Equity Used For Funding Business Combination As A Percentage Of The Total
ProceedsFromEquityUsedForFundingBusinessCombinationAsAPercentageOfTheTotal
0.60
ctcx Notice Period Of Redemption Warrant
NoticePeriodOfRedemptionWarrant
P30D
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.331
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-3.30
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.35
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.44
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.331
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0
CY2023Q2 ctcx Fair Value Of Founder Shares On The Grant Date
FairValueOfFounderSharesOnTheGrantDate
5.26

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
ctcx-20230630_pre.xml Edgar Link unprocessable
0001193125-23-212538-index-headers.html Edgar Link pending
0001193125-23-212538-index.html Edgar Link pending
0001193125-23-212538.txt Edgar Link pending
0001193125-23-212538-xbrl.zip Edgar Link pending
ctcx-20230630.xsd Edgar Link pending
d510633d10q.htm Edgar Link pending
d510633dex106.htm Edgar Link pending
d510633dex107.htm Edgar Link pending
d510633dex311.htm Edgar Link pending
d510633dex312.htm Edgar Link pending
d510633dex321.htm Edgar Link pending
d510633dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ctcx-20230630_cal.xml Edgar Link unprocessable
ctcx-20230630_lab.xml Edgar Link unprocessable
ctcx-20230630_def.xml Edgar Link unprocessable
d510633d10q_htm.xml Edgar Link completed